ISLAMABAD, Nov 12, 2025: The Competition Commission of Pakistan (CCP) has approved the acquisition of Standpharm Pakistan (Private) Limited by Crest Garments International (Private) Limited. The transaction is part of an internal corporate restructuring, with both entities under the common ownership and management of the same group of individual shareholders.
Standpharm Pakistan, which operates in the pharmaceutical and nutraceutical sectors, offers a broad range of products across 19 therapeutic categories, including anti-rheumatics, analgesics, vitamins, antibiotics, and psycholeptics. In contrast, Crest Garments International is primarily involved in garment manufacturing and has no operations in the pharmaceutical or nutraceutical markets.
After a thorough assessment, the CCP determined that the acquisition does not result in any horizontal, vertical, or conglomerate overlaps between the two companies. The pharmaceutical and nutraceutical sectors in Pakistan remain competitive, with a wide array of active players, moderate market concentration, and continued market entry by new firms. As such, the transaction is not expected to reduce competition or create a dominant position in any relevant market.
The CCP also highlighted that this acquisition constitutes an intra-group restructuring, leading to no change in ultimate control or management. Existing market dynamics and competitive pressures in the pharmaceutical and nutraceutical sectors will remain unaffected.
